Leerink Partners analyst Mike Kratky has maintained their bullish stance on ISRG stock, giving a Buy rating yesterday.Stay Ahead of the ...
10h
Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.
In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback